Pediatric Neuroscience Symposium 2020

Children with Neurological and Neurosurgical Conditions: An Update for Pediatricians

In this virtual course, leading specialists in pediatric neurosurgery will provide an update on the latest advances in management and treatment options for patients with pediatric neurological conditions. The three-hour activity is designed for physicians in pediatric, general, and family practice, pediatric neurologists, nurses, as well as physical and occupational therapists.

Course Directors

David I. Sandberg, MD, FAANS, FACS, FAAP
Professor and Director of Pediatric Neurosurgery
Dr. Marnie Rose Professor in Pediatric Neurosurgery
Departments of Pediatric Surgery and Neurosurgery
McGovern Medical School at UTHealth
Children’s Memorial Hermann Hospital and Mischer Neuroscience Institute

Faculty Speakers

Stephen A. Fletcher, DO
Associate Professor,
Departments of Pediatric Surgery and Neurosurgery
Division of Pediatric Neurosurgery
McGovern Medical School at UTHealth

Manish N. Shah, MD, FAANS
Director, Pediatric Spasticity and Epilepsy Surgery
Director, Texas Comprehensive Spasticity Center
Associate Professor,
Departments of Pediatric Surgery and Neurosurgery
Division of Pediatric Neurosurgery
McGovern Medical School at UTHealth

Program

  • New Advances in Treatment of Craniosynostosis  | Dr. Manish Shah
  • Modern Management of Hydrocephalus and Arachnoid Cysts  | Dr. David Sandberg
  • The Neurology and Surgical Treatment of Pathological Conditions at the Craniocervical Junction | Dr. Stephen Fletcher
  • Update on Pediatric Brain Tumors:  What the Pediatrician Should Know | Dr. David Sandberg
  • Update on Cerebral Palsy Treatments for Therapists and Pediatricians  | Dr. Manish Shah
  • The Neurology of Urology  | Dr. Stephen Fletcher

Learning Objectives

  • Discuss which craniosynostosis patients may benefit from endoscopic treatment.
  • Determine which craniosynostosis patients may benefit from distractor placement.
  • Describe the most common presenting signs and symptoms of hydrocephalus in children of different ages.
  • Recognize which patients could benefit from endoscopic management of hydrocephalus instead of shunting.
  • Describe which patients may benefit from the selective dorsal rhizotomy procedure.
  • Discuss the benefits of treating patients who have low-GMFCS cerebral palsy.
  • Describe the neuroanatomy of the craniocervical junction.
  • Describe the potential for pathological conditions due to abnormalities in the craniocervical junction and how those diseases present in children.
  • List the conditions that necessitate a neuro-urology workup.
  • List the most common presenting signs and symptoms of brain tumors in children.
  • Describe the latest treatment options for children once a brain tumor is diagnosed.

Accreditation Information

CME: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for continuing Medical Education (ACCME) through the joint providership of Antidote Education Company, Children’s Memorial Hermann Hospital and UT Health. Antidote is accredited by the ACCME to provide continuing medical education for physicians. Antidote designates this internet enduring material activity for a maximum of 3.0 AMA PRA Category 1 Credits™.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: Memorial Hermann Health System is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

OT: Memorial Hermann Health System is an AOTA Approved Provider of continuing education.  This course is offered for up to 3.0 AOTA CEUs/3 contact hours.  The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures from AOTA.  AOTA Classification Code:  Occupational Therapy Process- Treatment.  Participants must attend the entire course in order to receive a course certificate.  No partial credits will be given.

PT: Memorial Hermann Health System is TPTA Approved Provider of continuing education.  This course meets continuing competence requirements for physical therapist and physical therapist assistant licensure renewal in Texas for up to 3.0 CCUs. The assignment of Texas PT CCUs does not imply the endorsement of specific course content, products, or clinical procedures by TPTA or TBPTE. Participants must attend the entire course in order to receive a course certificate.  No partial credits will be given.

Disclosure

Antidote is committed to creating, developing, and operating high-quality, relevant, and practical continuing medical education activities that are in compliance with the ACCME’s policies on commercial support and disclosure. Specifically, we are dedicated to ensuring that our events are planned and implemented free of the control of commercial interests and to identifying and resolving conflicts of interest of all persons in a position to control the content of an educational activity before the educational activity is delivered to our attendees. In addition, it is our standard practice to disclose all relevant financial relationships of our speakers in writing to our attendees before the beginning of an educational activity.

Individuals in a position to control the content of this CME activity reported the following relevant financial relationships with commercial interests.

The following individuals have indicated no conflicts of interest to disclosure: David I. Sandberg, MD (presenter & planner), Stephen A Fletcher, DO (presenter), Manish N. Shah, MD (presenter), Alisse Pratt, Celeste Wilson, Michael O. Fleming, MD and Matthew Fleming (Antidote Education Company).

Disclaimer

The material presented in this course is being made available by Antidote Education Company the Institute for Extracorporeal Life Support for educational purposes only. This material is not intended to represent the best or only methods or procedures appropriate for the medical situations discussed, but rather is intended to present an approach, view, statement or opinion of the faculty which may be helpful to others who face similar situations. Opinions expressed in this activity are those of the faculty and not of Antidote.

Every effort has been made to assure the accuracy of the data presented at this course. Physicians may care to check specific details such as drug doses and contraindications in standard sources prior to clinical application.

Off-label or Investigational Use

The planners and presenters indicated that no off-label or investigational use would be discussed in this activity.

Privacy Policy

UTHealth Website Privacy and Security Policy